Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-25 @ 7:27 PM
Study NCT ID:
NCT01541332
Status:
UNKNOWN
Last Update Posted:
2016-03-10
First Post:
2012-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
Sponsor:
Oncotherapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-12
Completion Date Type:
ESTIMATED
First Submit Date:
2012-02-20
First Submit QC Date:
None
Study First Post Date:
2012-02-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-08
Last Update Post Date:
2016-03-10
Last Update Post Date Type:
ESTIMATED